Our People

With over 23 years of experience in the pharmaceutical industry, Greg has built a distinguished career marked by excellence, innovation and leadership. Specializing in long-term care (LTC) for the past 15 years, Greag has been instrumental in launching six successful products and contributing to the growth of four start-up ventures.

Throughout his career, Greg has held a variety of impactful roles spanning sales, sales leadership, and market access. His results-driven approach and commitment to excellence have been recognized with six President’s Club awards, a testament to his ability to exceed performance goals and drive success across diverse teams and initiatives.

Rommel Fernandez is a commercial strategy executive with over 17 years of experience driving growth and innovation in the pharmaceutical and biotechnology industries. He has played a pivotal role in the commercialization and launch of six pharmaceutical products, delivering measurable outcomes for patients, providers, and stakeholders.

As Chief Analytics Officer at Fingerpaint Group, Rommel led the integration of advanced analytics and generative AI into business operations, achieving a 6x efficiency gain and improving forecasting accuracy. At La Jolla Pharmaceutical, he was instrumental in the launch of Giapreza, securing over 300 formulary approvals, and access into some of the most high control health systems, and increasing hospital reimbursements for Medicare patients by 50% through strategic NTAP designation.

Rommel excels at aligning cross-functional teams, developing data-driven strategies, and executing initiatives that transform business operations. His expertise spans market access, commercialization, financial modeling, and lifecycle management, consistently contributing to organizational growth and market success.  Rommel combines strategic insight with operational excellence to deliver impactful results across healthcare markets.

Kurt has over 30 years of experience in health care, with a strong background in both clinical practice and the life science industry.  He possesses broad therapeutic experience and has supported the launch of 9 new products and new indications in that time.

Prior to joining Alpha Cognition, Kurt was Executive Director of Field Medical, Medical Operations, and Medical Communications at Reneo Pharmaceuticals.  During his tenure at Reneo, he was instrumental in building Medical Affairs teams and infrastructure and preparing for product launch.  Prior to that, Kurt served as Head of US Medical Affairs at Acacia Pharma, Inc., and built and led the Medical Affairs organization through the successful launch of two new products.  On his way to these leadership roles, Kurt has served in positions of increasing responsibility at Acadia Pharmaceuticals, Avanir Pharmaceuticals, Centocor/Johnson & Johnson, and Glaxo Wellcome.  His pharmacy clinical practice experience includes Cox Health Systems in Springfield, MO; Express Scripts in St. Louis, MO; and Senior Scripts, a long-term care pharmacy, in Chesterfield, MO; where, in each setting, he also held positions of leadership.

Kurt earned Bachelor of Science in Pharmacy and Doctor of Pharmacy degrees from the St. Louis College of Pharmacy and a Master’s in Business Administration from Southern Illinois University at Edwardsville.  He completed residency training at University of Florida Health Science Center in Jacksonville.  Kurt is a registered pharmacist in the State of Missouri. 

Nam is a seasoned Commercial Operations manager with over 12 years of experience within the Biopharmaceuticals industry, supporting sales across multiple specialty and rare therapeutics, including CNS, Nephrology, Bile Acid, and Psychiatry.

Nam has established operational processes, including building systems for BI reporting and data warehousing, overseeing the design/implementation of Incentive Compensation plans, and providing analytical support to commercial organizations.

Nam is highly motivated and eager to contribute to ZUNVEYL's success and to help benefit patients in long-term care.

Jack Kelly brings over 30 years of experience in roles of increasing responsibility in the pharmaceutical industry with Bristol-Myers Squibb, Daiichi Sankyo (DSI), & most recently Arbor Pharmaceuticals. He has enjoyed the last 20-plus years of his career in Market Access Department Leadership successfully developing and implementing launch strategies, while growing numerous products in the central nervous system, cerebrovascular, cardiovascular, antibiotic, 505(B)(2), & rare orphan disease therapeutic areas by delivering value-added solutions and services to customers & patients.

Jack has led strategic account management and contract negotiations with the commercial managed care, Medicare, prescription benefit managers, Medicaid, federal government, institutional, trade, retail & specialty pharmacy business sectors. He has successfully built Managed Markets & Trade Departments including directors, trainers and managed care marketers at both DSI & Arbor, while establishing strong and active relationships alongside his national & regional account teams with key decision-makers, influencers, and stakeholders.

Since obtaining his degree in Pharmacy, Jack's mission perseveres to improve health outcomes and access to innovative therapies through collaboration and partnerships within our challenging managed markets environment while protecting gross-to-net revenues.

Jen Pesa brings 25 years in pharmaceutical commercial leadership. She is an authentic and dynamic leader known for her ability to drive results and build high-performing teams. She has led the successful launch of 12 products across 13 therapeutic areas, including neurology, psychiatry, geriatrics, and more. With 14 years focused on long-term care, Jen has a unique understanding of the complexities of this segment, and is skilled at developing strategies that improve both patient outcomes and healthcare delivery. A passionate advocate for building commercial capabilities, she has a proven track record in driving cross-functional collaboration and aligning teams across marketing, market access, sales operations, and sales training to create sustainable business success.

Jen’s leadership style is rooted in authenticity and collaboration, and she is committed to fostering a culture of innovation, accountability, and growth at every level of her organizations.

Leena joins Alpha Cognition's marketing team, bringing her expertise in developing LTC-specific marketing strategies and promotional materials to the launch of ZUNVEYL. Leena's prior experience includes excelling in LTC sales, revitalizing an underperforming territory in just a few short months, and leading impactful marketing campaigns, including the first-ever LTC-focused campaign at her previous organization. She has also developed CNS-focused KOL marketing initiatives, sales force resources, and non-personal promotion. Passionate about innovation in long-term care, Leena is eager to drive ZUNVEYL's success in the LTC segment.

Trierre is an inspirational and dynamic leader known for achieving superior results with a people-first approach. Over the past 15 years, Trierre has focused on the long-term care (LTC) market, holding roles such as Pharmaceutical Sales Representative, LTC Regional Business Manager, LTC National Account Manager, Senior District Business Manager, and Business Development Director for an LTC pharmacy.

Trierre has been the recipient of four Sales Elite Trips and nine Top Product Sales Awards. She has consistently been honored for exceeding targets and driving revenue growth. Her strategic focus, competitive spirit, and ability to achieve results through people will be a tremendous asset to Alpha Cognition. Trierre brings an in-depth knowledge of the complexities of the LTC segment, understanding the unique challenges and opportunities within this market. Her expertise will be invaluable as we navigate the evolving landscape of long-term care.

With more than three decades of experience in pharmaceutical and biotechnology sales, Michael’s career is a testament to his unwavering dedication and expertise. His extensive background includes over 15 years in sales leadership and market access, where he played a pivotal role in building two commercial sales organizations from the ground up and successfully launching ten groundbreaking products.

At the heart of Michael’s career is his dedication to the Long-Term Care and CNS markets. His influence in these fields has been transformative, including his leadership in developing a strategic sales model now recognized as the standard in the long-term care industry. Michael’s passion, combined with his depth of experience, makes him an invaluable addition to our team as we continue to drive innovation and excellence in these critical areas of care.

Junko is an experienced accounting professional with over 15 years in both public practice and industry. After earning her Bachelor’s degree in Accounting, she completed her Canadian Chartered Professional Accountant designation in 2012. Throughout her career, Junko has developed a comprehensive skill set, providing expert financial analysis, reporting, and strategic advisory services across various sectors.

Before officially joining Alpha Cognition team, Junko had been consulting with the company since 2019.  During this time, she played a key role in overseeing the financial records, preparing quarterly and year end reporting under IFRS and US GAAP, and leading the year end audit processes.

Tom Tobin is a seasoned pharmaceutical leader with over 20 years of experience in pricing, contracting, and trade strategy.  Throughout his career, Tom has held senior roles at leading organizations, including Impel Pharmaceuticals, Esperion, Auxilium Pharmaceuticals, and AstraZeneca. His expertise spans managed care contract strategy, government pricing compliance, and account management, with a proven track record of building strategic partnerships across PBMs, HMOs, Medicare, and government sectors.

Tom’s leadership is defined by his ability to align operational excellence with brand goals, leveraging deep analytical insights and negotiation skills to deliver impactful results. He is passionate about improving patient access to life-changing treatments and driving value for stakeholders.

Kumar Vaddi brings 20 years of pharmaceutical CMC experience focused on formulation development, scale up, manufacturing, analytical, regulatory preparedness, and leadership in both internal and external collaborations at various stages of drug substance and drug product development. Prior to joining Alpha Cognition, Kumar developed innovative solutions in drug development including oral solids, soft gels, semi solids, liquids, nasal sprays, and transdermal formulations at Novartis and Noven Pharmaceuticals. Kumar holds a Ph.D. in Pharmaceutical Sciences, complemented by post-doctoral fellowships at the University of Kentucky and Texas A&M University. He has also contributed to the field through multiple published papers and books. As a registered pharmacist and affiliate member of Florida Atlantic University, Kumar stays active and engaged with the academic and professional community.

Andy brings over a decade of experience in Medical Affairs within the pharmaceutical industry. He has excelled in diverse roles across multiple therapeutic areas, driving strategic initiatives and playing a significant role in the successful launch of 4 new products.

Prior to joining Alpha Cognition, Andy was a Medical Science Liaison at Reneo Pharmaceuticals, Marinus Pharmaceuticals and Acacia Pharma. In addition to his field medical duties, he worked collaboratively to build out Medical Affairs teams and supported medical-specific and company-wide training initiatives. At Avanir Pharmaceuticals, Andy led the Medical Information department during the launch of a new migraine product and supported HEOR activities by conducting real-world evidence studies, authoring dossiers, and creating clinical presentations for payor audiences. He is passionate about communicating information and evidence to ensure optimal patient access and outcomes.

Andy earned his Bachelor of Science degree in Biological Sciences from the University of California, Irvine and Doctor of Pharmacy degree from the University of California, San Diego.  After pharmacy school, he completed a Post-doctoral Pharmaceutical Fellowship at AbbVie, formally Allergan, and the University of Southern California. Andy is a registered pharmacist in the State of California.

Jenny brings over 17 years of experience in the pharmaceutical industry, including 11 years dedicated to the long-term care space. She has developed a deep understanding of the unique challenges faced by caregivers and providers in supporting residents. Her focus and passion lie in bringing options that appropriately support residents and positively impact their lives and the teams who care for them.

In addition to her expertise, Jenny is known for her fun and encouraging leadership style. She values authenticity and teamwork, fostering a culture of collaboration, accountability, and growth, empowering her teams to drive progress and excellence in the long-term care space.